These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 20298652)

  • 41. Scanning electron microscopy evaluation of the hard tissue barrier after pulp capping with calcium hydroxide, mineral trioxide aggregate (MTA) or ProRoot MTA.
    Reston EG; de Souza Costa CA
    Aust Endod J; 2009 Aug; 35(2):78-84. PubMed ID: 19703080
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of bioactive glass, mineral trioxide aggregate, ferric sulfate, and formocresol as pulpotomy agents in rat molar.
    Salako N; Joseph B; Ritwik P; Salonen J; John P; Junaid TA
    Dent Traumatol; 2003 Dec; 19(6):314-20. PubMed ID: 15022999
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mineral trioxide aggregate as a pulpotomy medicament: an evidence-based assessment.
    Ng FK; Messer LB
    Eur Arch Paediatr Dent; 2008 Jun; 9(2):58-73. PubMed ID: 18534173
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Repair of furcal perforation treated with mineral trioxide aggregate in a primary molar tooth: 20-month follow-up.
    Oliveira TM; Sakai VT; Silva TC; Santos CF; Machado MA; Abdo RC
    J Dent Child (Chic); 2008; 75(2):188-91. PubMed ID: 18647517
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mineral trioxide aggregate as pulp dressing agent in pulpotomy treatment of primary molars: 42-month clinical study.
    Maroto M; Barbería E; Vera V; García-Godoy F
    Am J Dent; 2007 Oct; 20(5):283-6. PubMed ID: 17993022
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative evaluation of formocresol and mineral trioxide aggregate in pulpotomized primary molars--2 year follow up.
    Airen P; Shigli A; Airen B
    J Clin Pediatr Dent; 2012; 37(2):143-7. PubMed ID: 23534319
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CAT of the month. Mineral trioxide aggregate (MTA) successful for pulpotomy treatment (UT CAT #2296).
    Alsalman Z; Philip J; Norling B
    Tex Dent J; 2012 Oct; 129(10):1074. PubMed ID: 23311027
    [No Abstract]   [Full Text] [Related]  

  • 48. Primary molar pulpotomy: a systematic review and network meta-analysis.
    Lin PY; Chen HS; Wang YH; Tu YK
    J Dent; 2014 Sep; 42(9):1060-77. PubMed ID: 24513112
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calcium hydroxide vs mineral trioxide aggregates for partial pulpotomy of permanent molars with deep caries.
    Qudeimat MA; Barrieshi-Nusair KM; Owais AI
    Eur Arch Paediatr Dent; 2007 Jun; 8(2):99-104. PubMed ID: 17555692
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mineral trioxide aggregate versus calcium hydroxide for pulpotomy in primary molars.
    Liu H; Zhou Q; Qin M
    Chin J Dent Res; 2011; 14(2):121-5. PubMed ID: 22319753
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and histological evaluation of white ProRoot MTA in direct pulp capping.
    Iwamoto CE; Adachi E; Pameijer CH; Barnes D; Romberg EE; Jefferies S
    Am J Dent; 2006 Apr; 19(2):85-90. PubMed ID: 16764130
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mineral trioxide aggregate as a pulpotomy agent in primary molars: an in vivo study.
    Naik S; Hegde AH
    J Indian Soc Pedod Prev Dent; 2005 Mar; 23(1):13-6. PubMed ID: 15858300
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MTA pulpotomy of human permanent molars with irreversible pulpitis.
    Eghbal MJ; Asgary S; Baglue RA; Parirokh M; Ghoddusi J
    Aust Endod J; 2009 Apr; 35(1):4-8. PubMed ID: 19335509
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical and Radiographic Evaluation of the Effectiveness of Formocresol, Mineral Trioxide Aggregate, Portland Cement, and Enamel Matrix Derivative in Primary Teeth Pulpotomies: A Two Year Follow-Up.
    Yildirim C; Basak F; Akgun OM; Polat GG; Altun C
    J Clin Pediatr Dent; 2016; 40(1):14-20. PubMed ID: 26696101
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Histological, ultrastructural and quantitative investigations on the response of healthy human pulps to experimental capping with mineral trioxide aggregate: a randomized controlled trial.
    Nair PN; Duncan HF; Pitt Ford TR; Luder HU
    Int Endod J; 2008 Feb; 41(2):128-50. PubMed ID: 17956562
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mineral trioxide aggregate material use in endodontic treatment: a review of the literature.
    Roberts HW; Toth JM; Berzins DW; Charlton DG
    Dent Mater; 2008 Feb; 24(2):149-64. PubMed ID: 17586038
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Maturogenesis of a cariously exposed immature permanent tooth using MTA for direct pulp capping: a case report.
    Patel R; Cohenca N
    Dent Traumatol; 2006 Dec; 22(6):328-33. PubMed ID: 17073926
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of sodium hypochlorite application on the success of calcium hydroxide and mineral trioxide aggregate pulpotomies in primary teeth.
    Akcay M; Sari S
    Pediatr Dent; 2014; 36(4):316-21. PubMed ID: 25197997
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Randomized Controlled Trial Comparing the Success of Mineral Trioxide Aggregate and Ferric Sulfate as Pulpotomy Medicaments for Primary Molars.
    Cordell S; Kratunova E; Marion I; Alrayyes S; Alapati SB
    J Dent Child (Chic); 2021 May; 88(2):120-128. PubMed ID: 34321144
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinical and radiographic evaluation of pulpotomies employing calcium hydroxide and trioxide mineral aggregate.
    Percinoto C; de Castro AM; Pinto LM
    Gen Dent; 2006; 54(4):258-61. PubMed ID: 16903198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.